Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 29 | 2025 | 12253 | 2.450 |
Why?
|
Prediabetic State | 4 | 2023 | 548 | 1.350 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2024 | 3253 | 1.150 |
Why?
|
Digoxin | 2 | 2024 | 246 | 1.020 |
Why?
|
Insulin Resistance | 7 | 2025 | 3982 | 0.870 |
Why?
|
Cardiovascular Diseases | 12 | 2024 | 15661 | 0.780 |
Why?
|
Resistance Training | 1 | 2024 | 199 | 0.770 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3110 | 0.710 |
Why?
|
Netherlands | 7 | 2024 | 2277 | 0.710 |
Why?
|
Biguanides | 1 | 2020 | 21 | 0.690 |
Why?
|
Epoprostenol | 1 | 2021 | 246 | 0.690 |
Why?
|
Insulin | 7 | 2022 | 6610 | 0.690 |
Why?
|
Blood Glucose | 9 | 2024 | 6435 | 0.680 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5892 | 0.660 |
Why?
|
Metformin | 2 | 2024 | 909 | 0.660 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2023 | 3447 | 0.650 |
Why?
|
Death, Sudden, Cardiac | 2 | 2024 | 1568 | 0.620 |
Why?
|
Sulfonylurea Compounds | 1 | 2020 | 220 | 0.600 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 426 | 0.580 |
Why?
|
Asthma | 4 | 2017 | 6293 | 0.580 |
Why?
|
Longitudinal Studies | 12 | 2024 | 14794 | 0.540 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2911 | 0.530 |
Why?
|
Cholesterol, LDL | 2 | 2024 | 2403 | 0.490 |
Why?
|
Hypertension | 4 | 2024 | 8617 | 0.460 |
Why?
|
Cardiovascular System | 1 | 2022 | 841 | 0.460 |
Why?
|
Anti-Asthmatic Agents | 2 | 2016 | 577 | 0.460 |
Why?
|
Lipids | 2 | 2024 | 3345 | 0.440 |
Why?
|
Cardiovascular Agents | 2 | 2018 | 849 | 0.410 |
Why?
|
Heart Rate | 2 | 2023 | 4217 | 0.370 |
Why?
|
Hypercholesterolemia | 1 | 2018 | 1145 | 0.360 |
Why?
|
Genotype | 3 | 2024 | 13048 | 0.360 |
Why?
|
Developing Countries | 1 | 2023 | 2911 | 0.360 |
Why?
|
Humans | 66 | 2025 | 768970 | 0.350 |
Why?
|
Hyperglycemia | 1 | 2019 | 1389 | 0.350 |
Why?
|
Cardiotonic Agents | 2 | 2024 | 544 | 0.340 |
Why?
|
Risk Factors | 23 | 2024 | 74976 | 0.330 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 16053 | 0.320 |
Why?
|
Breast Feeding | 1 | 2017 | 1364 | 0.320 |
Why?
|
Cognition Disorders | 1 | 2023 | 3985 | 0.310 |
Why?
|
Long QT Syndrome | 2 | 2024 | 472 | 0.300 |
Why?
|
China | 4 | 2022 | 2395 | 0.300 |
Why?
|
Prospective Studies | 16 | 2024 | 54962 | 0.300 |
Why?
|
Exercise | 2 | 2024 | 5954 | 0.300 |
Why?
|
Female | 39 | 2024 | 397515 | 0.270 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6569 | 0.270 |
Why?
|
Male | 33 | 2024 | 365203 | 0.260 |
Why?
|
Iran | 3 | 2024 | 763 | 0.250 |
Why?
|
Blood Pressure | 6 | 2024 | 8544 | 0.250 |
Why?
|
Kidney | 1 | 2021 | 7058 | 0.250 |
Why?
|
Aged | 19 | 2024 | 171786 | 0.250 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2059 | 0.250 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39394 | 0.230 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2024 | 37 | 0.220 |
Why?
|
European Union | 1 | 2024 | 158 | 0.220 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2434 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2024 | 10400 | 0.220 |
Why?
|
Bifidobacterium | 1 | 2023 | 99 | 0.210 |
Why?
|
Bacteroides | 1 | 2023 | 165 | 0.210 |
Why?
|
Glucose | 3 | 2023 | 4352 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
Cohort Studies | 8 | 2024 | 41808 | 0.200 |
Why?
|
Microvascular Angina | 1 | 2022 | 14 | 0.200 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2024 | 10765 | 0.200 |
Why?
|
Atrioventricular Block | 1 | 2023 | 141 | 0.180 |
Why?
|
Child, Preschool | 6 | 2023 | 42683 | 0.180 |
Why?
|
Stillbirth | 1 | 2024 | 381 | 0.180 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2023 | 268 | 0.180 |
Why?
|
Middle Aged | 17 | 2024 | 223737 | 0.170 |
Why?
|
Disease Progression | 3 | 2025 | 13674 | 0.170 |
Why?
|
Polyneuropathies | 1 | 2021 | 139 | 0.170 |
Why?
|
Singapore | 1 | 2020 | 299 | 0.170 |
Why?
|
Blood Sedimentation | 1 | 2020 | 236 | 0.160 |
Why?
|
RNA, Bacterial | 1 | 2021 | 393 | 0.160 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2024 | 365 | 0.160 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.160 |
Why?
|
Fasting | 3 | 2021 | 1610 | 0.160 |
Why?
|
Asia | 1 | 2020 | 630 | 0.160 |
Why?
|
Phytoestrogens | 1 | 2018 | 59 | 0.160 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7478 | 0.150 |
Why?
|
Carotid Arteries | 1 | 2023 | 943 | 0.150 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.150 |
Why?
|
Child | 8 | 2023 | 80960 | 0.150 |
Why?
|
Thyrotropin | 1 | 2021 | 834 | 0.150 |
Why?
|
Cholesterol, HDL | 1 | 2024 | 1820 | 0.140 |
Why?
|
Pericardium | 1 | 2022 | 679 | 0.140 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12801 | 0.140 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26395 | 0.140 |
Why?
|
Dyslipidemias | 1 | 2024 | 873 | 0.130 |
Why?
|
Gastric Mucosa | 1 | 2019 | 602 | 0.130 |
Why?
|
Metabolomics | 2 | 2023 | 1675 | 0.130 |
Why?
|
Triglycerides | 1 | 2024 | 2464 | 0.130 |
Why?
|
Cataract | 1 | 2022 | 837 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2023 | 781 | 0.130 |
Why?
|
Mass Spectrometry | 1 | 2023 | 2204 | 0.130 |
Why?
|
Troponin I | 1 | 2020 | 662 | 0.130 |
Why?
|
Fatigue | 1 | 2023 | 1557 | 0.130 |
Why?
|
Obesity | 6 | 2023 | 13091 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2360 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2023 | 1014 | 0.130 |
Why?
|
Glaucoma, Open-Angle | 1 | 2022 | 742 | 0.130 |
Why?
|
Adolescent | 6 | 2023 | 89244 | 0.120 |
Why?
|
Cognition | 2 | 2023 | 7081 | 0.120 |
Why?
|
Glomerular Filtration Rate | 2 | 2023 | 2228 | 0.120 |
Why?
|
Headache | 1 | 2023 | 1264 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Infant | 6 | 2024 | 36556 | 0.120 |
Why?
|
Macular Degeneration | 1 | 2022 | 1016 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1738 | 0.120 |
Why?
|
C-Reactive Protein | 3 | 2023 | 3859 | 0.120 |
Why?
|
Electrocardiography | 3 | 2023 | 6413 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2020 | 1161 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2023 | 2820 | 0.110 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1169 | 0.110 |
Why?
|
Diabetic Nephropathies | 1 | 2020 | 973 | 0.110 |
Why?
|
Interleukin-6 | 2 | 2020 | 3232 | 0.110 |
Why?
|
Phenotype | 2 | 2022 | 16731 | 0.100 |
Why?
|
Adiposity | 1 | 2023 | 1895 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2019 | 985 | 0.100 |
Why?
|
Medication Errors | 1 | 2018 | 785 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2614 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1542 | 0.100 |
Why?
|
Coronary Vessels | 1 | 2023 | 3124 | 0.100 |
Why?
|
Prevalence | 3 | 2022 | 15879 | 0.100 |
Why?
|
Inflammation | 3 | 2023 | 10868 | 0.100 |
Why?
|
Prescription Drugs | 1 | 2018 | 635 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 3 | 2022 | 18068 | 0.090 |
Why?
|
Hospitalization | 3 | 2024 | 10847 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1119 | 0.090 |
Why?
|
Incidence | 3 | 2019 | 21547 | 0.090 |
Why?
|
Adult | 10 | 2024 | 223851 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2216 | 0.090 |
Why?
|
Life Style | 1 | 2021 | 3931 | 0.080 |
Why?
|
Time Factors | 2 | 2024 | 40261 | 0.080 |
Why?
|
Body Mass Index | 4 | 2023 | 13055 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1483 | 0.080 |
Why?
|
Odds Ratio | 2 | 2021 | 9684 | 0.080 |
Why?
|
Waist Circumference | 2 | 2023 | 935 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2297 | 0.080 |
Why?
|
Risk | 2 | 2021 | 9621 | 0.080 |
Why?
|
Health Status | 1 | 2022 | 4095 | 0.080 |
Why?
|
Hypersensitivity | 1 | 2017 | 1173 | 0.080 |
Why?
|
Pain | 1 | 2023 | 5100 | 0.070 |
Why?
|
Young Adult | 4 | 2021 | 60131 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3785 | 0.070 |
Why?
|
Homeostasis | 1 | 2018 | 3347 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1892 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7460 | 0.070 |
Why?
|
Infant, Newborn | 4 | 2024 | 26428 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2021 | 81903 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 65480 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3554 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3811 | 0.070 |
Why?
|
Neoplasms | 1 | 2015 | 22389 | 0.070 |
Why?
|
Mendelian Randomization Analysis | 2 | 2022 | 1040 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2018 | 3443 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8055 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5176 | 0.060 |
Why?
|
Risk Assessment | 2 | 2024 | 24333 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 14201 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10115 | 0.050 |
Why?
|
Logistic Models | 1 | 2017 | 13318 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6401 | 0.050 |
Why?
|
Cystatin C | 1 | 2023 | 272 | 0.050 |
Why?
|
Waist-Hip Ratio | 1 | 2023 | 520 | 0.050 |
Why?
|
Vaccination | 2 | 2024 | 3438 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 246 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18435 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 391 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8749 | 0.040 |
Why?
|
Albumins | 1 | 2023 | 577 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2024 | 592 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 22296 | 0.040 |
Why?
|
Proteinuria | 1 | 2023 | 610 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 2024 | 704 | 0.040 |
Why?
|
Albuminuria | 1 | 2023 | 658 | 0.040 |
Why?
|
Milk | 1 | 2022 | 438 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30046 | 0.040 |
Why?
|
Coffee | 1 | 2023 | 594 | 0.040 |
Why?
|
Magnesium | 1 | 2021 | 816 | 0.040 |
Why?
|
Gastroscopy | 1 | 2019 | 213 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15951 | 0.040 |
Why?
|
Thyroxine | 1 | 2021 | 665 | 0.040 |
Why?
|
Beverages | 1 | 2023 | 819 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 789 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1917 | 0.040 |
Why?
|
Adiponectin | 1 | 2023 | 1117 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1048 | 0.030 |
Why?
|
Microcirculation | 1 | 2022 | 1281 | 0.030 |
Why?
|
Intra-Abdominal Fat | 1 | 2022 | 625 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2021 | 552 | 0.030 |
Why?
|
Genetic Variation | 2 | 2021 | 6611 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2022 | 1617 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59739 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2018 | 496 | 0.030 |
Why?
|
Interleukin-1 | 1 | 2018 | 1251 | 0.030 |
Why?
|
Leptin | 1 | 2023 | 1597 | 0.030 |
Why?
|
Feces | 1 | 2021 | 1510 | 0.030 |
Why?
|
Quality of Life | 1 | 2015 | 13510 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2023 | 2748 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2913 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2974 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2258 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1423 | 0.030 |
Why?
|
Mothers | 1 | 2023 | 2209 | 0.030 |
Why?
|
Genetic Loci | 1 | 2022 | 2630 | 0.030 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2024 | 2190 | 0.020 |
Why?
|
Premature Birth | 1 | 2024 | 1830 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5891 | 0.020 |
Why?
|
Alleles | 1 | 2022 | 6901 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3782 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2022 | 3335 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6346 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4356 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12562 | 0.020 |
Why?
|
Diet | 1 | 2023 | 8088 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10633 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30265 | 0.010 |
Why?
|
United States | 1 | 2021 | 73186 | 0.010 |
Why?
|
Animals | 1 | 2022 | 169335 | 0.010 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_